Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_assertion type Assertion NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_head.
- NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_assertion description "[In contrast, the glucocorticoid receptor and its cognate ligand have long been known to promote type II pneumocyte maturation; prenatal administration of glucocorticoids is commonly used to attenuate the severity of infant respiratory distress syndrome (RDS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_provenance.
- NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_assertion evidence source_evidence_literature NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_provenance.
- NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_assertion SIO_000772 22001906 NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_provenance.
- NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_assertion wasDerivedFrom befree-20150227 NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_provenance.
- NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_assertion wasGeneratedBy ECO_0000203 NP435079.RAeyJTfwJT1lRKtrsKg7g-uuq0uBlmcGebtBlG5BVLD54130_provenance.